Scancell Could Explode Any Time!

New Post Public Reply Private Reply Replies (1) Message Board
Banshee Buckaroo

Scancell Could Explode Any Time!

At the moment Scancell Holdings (SCNLF) stands at 53 cents a share. Last April Inovio, which also develops DNA cancer vaccines was also at 53 cents and had a market cap lower than Scancell's is now. Then Inovio's Dr. Kim, started putting it about that there was a 'big partner' in the wings. The share price soared on the back of this and when a deal actually surfaced in September the shares exploded. Roche had decided to license two of Inovio's preclinical vaccines; one for prostate cancer and one for hepatitis. Today Inovio's shares stand at around $3.70. Nothing like a deal with a big partner to get shares to take


So what's the relevance for Scancell? Well it all comes down to the increasing interest in combining DNA cancer vaccines with a new class of drugs known as PD-1 inhibitors. Roche, Bristol Myers Squibb and Merck & Co are the big three manufacturers of these anti-PD-1 drugs which have boomed in interest, making them the big pharmaceutical story of 2013.

PD-1 inhibitors work by blocking the anti-immune effects of the PD-1 protein which cancer cells use to switch off killer CD8 T cells preventing them from attacking and eradicating tumors. Problem is, these drugs that put pay to cancer's PD-1 protection are only effective in helping around a third of recipients to fight the disease.

So Roche has had the bright idea of combining DNA cancer vaccines with the company's PD-1 inhibitor to give the treatment a 'one two punch.' So far Roche has only managed to do a deal for one preclinical DNA prostate cancer vaccine from Inovio.

But Roche's PD-1 inhibitor targets a whole range of other cancers such as malignant melanoma and lung cancer. Inovio doesn't have DNA vaccines to target these cancers but Scancell does. In fact Scancell is the only company that has DNA vaccines to target these conditions.

And it doesn't end there. Bristol and Merck, should they wish to emulate their rival, don't have any DNA vaccines to combine with their inhibitors at all. Scancell and Inovio are the only two companies developing DNA vaccines to target specific cancers that are suitable for combining with these new drugs. So with potentially three anti-PD-1 giants fighting over a handful of available vaccines, Scancell is hot favourite for the next big deal.

Of course Scancell is arguably a lot further along than Inovio with its SCIB1 DNA vaccine to treat malignant melanoma at Phase 2. Inovio does have a vaccine in Phase 2 to treat Cervical Intraepithelial Neoplasia (CIN) but this is a premalignant non-cancerous condition.

Last August the Nottingham Post reported that Scancell had receive 'unsolicited interest' in both its vaccine platforms, ImmunoBody and Moditope, from large pharmaceutical companies. And tantalizingly on 26th January 2014 Matthew Goodman in London's Sunday Times, referring to the encouraging data from SCIB1's Phase 2 trials, reported Scancell's Joint CEO Richard Goodfellow as saying, “We are looking at 2014 as the year we consummate a relationship or a deal to take this forward.”

At the moment Scancell's shares are 53 cents but they have a broker's target of £1.27 or around $2.10. But if the awaited licensing deals for either SCIB1 for melanoma or SCIB2 for lung cancer suddenly materializes, as investors hope, Scancell's shares could easily smash that target!


http://www.hotstockmarket.com/t/277760/scnlf-...st_3027438

Scancell Holdings PLC. (SCNLF) Stock Research Links

SCNLF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 106

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 56

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 258

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 145

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 104

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
Alliance for Women in Media Champions Change in 2026

Updated Category News Views 60

A Celebration of Trailblazing Women in Media If there's one thing I've learned about strong leadership, it's that you can't fake authenticity. Today, we're tipping our hats to some genuine trailblazers. The Alliance for Women in Media (AWM) held its annual Gracies Leadership Awards, celebrating the achievements and vision of seven remarkable women. Honoring the...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 39

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 50

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 283

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Dr. Obeng Joins WellcomeMD with Special Offer for Patients

Updated Category News Views 23

New Beginnings in Concierge Medicine In late October, WellcomeMD opened its doors to Dr. Paa-Kofi Obeng—an arrival greeted with considerable anticipation in Richmond's medical scene. This isn't just any run-of-the-mill staff addition; Dr. Obeng brings with him over a decade of experience from places like the Veterans Administration Medical Center. He's armed with a...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Consumer Trust: The Most Trusted Brands of 2026

Updated Category News Views 270

Consumer Trust at the Core of Shopping Decisions In an ever-competitive marketplace, consumers face an overwhelming array of choices, making decisions increasingly challenging. Fortunately, trust acts as a guiding beacon for shoppers, allowing them to confidently narrow down their options when making purchases. According to the BrandSpark American Trust Study, a...

Continue Reading
Saudi AI Hackathon 2025: Empowering Student Innovators

Updated Category News Views 215

Saudi AI & Edge Computing Hackathon 2025 Fosters Innovation In a remarkable showcase of talent and creativity, the Saudi AI & Edge Computing Hackathon 2025 took center stage, emphasizing the synergy between academia and the tech industry. Hosted by Prince Sultan University and backed by MemryX, this hackathon highlighted the exceptional capabilities of students from...

Continue Reading
Meta Implements AI Hiring Freeze Amid Talent Competition

Updated Category News Views 312

Meta Platforms Inc. Takes a Step Back in AI Hiring Meta Platforms Inc. (NASDAQ: META) has recently instituted a hiring freeze in its artificial intelligence division. This decision follows months of aggressive recruitment, during which the company significantly boosted its talent pool with substantial compensation offers. The freeze is aimed at regulating the hiring...

Continue Reading
Lady Gaga's Heartfelt Cover of 'Won't You Be My Neighbor?' in Super Bowl Teaser

Updated Category News Views 148

Lady Gaga Celebrates Community with New Cover In a touching tribute to the spirit of neighborliness, Lady Gaga has graced the world with her cover of "Won't You Be My Neighbor?". This initiative is part of a larger campaign that dives deep into themes of home, community, and belonging. Behind the Scenes of the Teaser Fans can catch exclusive behind-the-scenes footage...

Continue Reading
Palo Alto Networks Plummets: Guidance Cut or Market Misread?

Updated Category News Views 245

Palo Alto Networks took a nosedive, with shares down over 7% premarket, sitting at $151.69—a shocker for traders who were banking on bullish momentum. The cybersecurity giant's fiscal second-quarter report dropped Tuesday, revealing a mixed bag that left investors scrambling to recalibrate expectations. While the top line reported $2.59 billion in revenue—just edging...

Continue Reading